Successful treatment of Scedosporium pneumonia with voriconazole during AML therapy and bone marrow transplantation
- 22 September 2003
- journal article
- letter
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 41 (5) , 494-495
- https://doi.org/10.1002/mpo.10363
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- A Case of Disseminated Scedosporium Apiospermum Infection after Bone Marrow TransplantationMycoses, 2009
- New Drugs and Novel Targets for Treatment of Invasive Fungal Infections in Patients with CancerThe Oncologist, 2000
- Use of Voriconazole in Treatment of Scedosporium apiospermum Infection: Case ReportJournal of Clinical Microbiology, 1998
- Scedosporium Species Infections in Cancer PatientsInfectious Diseases in Clinical Practice, 1998
- In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogensAntimicrobial Agents and Chemotherapy, 1997
- Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydiiAntimicrobial Agents and Chemotherapy, 1995
- Successful Treatment of Simultaneous Pulmonary Pseudallescheria boydii and Aspergillus terreus Infection with Oral ItraconazoleClinical Infectious Diseases, 1993
- Successful Treatment of Pneumonia Due to Scedosporium apiospermum with Itraconazole: Case ReportClinical Infectious Diseases, 1993
- Pseudallescheria boydii Infection After Bone Marrow TransplantationAnnals of Internal Medicine, 1983